The Inhibrx Team

Mark P. Lappe
Mark P. Lappe

Founder, Chief Executive Officer

Brendan P. Eckelman, Ph.D.
Brendan P. Eckelman, Ph.D.

Founder, Chief Scientific Officer, EVP Corporate Strategy

Quinn Deveraux, Ph.D.
Quinn Deveraux, Ph.D.

Founder, EVP Early Research

Klaus W. Wagner, M.D., Ph.D.
Klaus W. Wagner, M.D., Ph.D.

EVP Chief Medical Officer

Kelly Deck, C.P.A.
Kelly Deck, C.P.A.

Chief Financial Officer

Ashraf Amanullah, Ph.D.
Ashraf Amanullah, Ph.D.

EVP, Chief Technical Operations Officer

Analeah Heidt, Ph.D.
Analeah Heidt, Ph.D.

EVP Translational Research

Jeffrey Jensen
Jeffrey Jensen

EVP Clinical Operations

John Timmer, Ph.D.
John Timmer, Ph.D.

VP Research

Leah Pollema, J.D.
Leah Pollema, J.D.

VP, General Counsel

The Inhibrx Board

Mark P. Lappe

Chairman

Brendan P. Eckelman, Ph.D.

Director

Douglas G. Forsyth

Director

Jon Faiz Kayyem, Ph.D.

Director

Kimberly Manhard

Director